These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30758992)

  • 21. Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome.
    Bos LD; Weda H; Wang Y; Knobel HH; Nijsen TM; Vink TJ; Zwinderman AH; Sterk PJ; Schultz MJ
    Eur Respir J; 2014 Jul; 44(1):188-97. PubMed ID: 24743964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid detection of sepsis in rats through volatile organic compounds in breath.
    Guamán AV; Carreras A; Calvo D; Agudo I; Navajas D; Pardo A; Marco S; Farré R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 881-882():76-82. PubMed ID: 22209594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis.
    Shestivska V; Dryahina K; Nunvář J; Sovová K; Elhottová D; Nemec A; Smith D; Španěl P
    J Breath Res; 2015 Apr; 9(2):027104. PubMed ID: 25830686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of breath volatile organic compounds as a noninvasive tool to diagnose nonalcoholic fatty liver disease in children.
    Alkhouri N; Cikach F; Eng K; Moses J; Patel N; Yan C; Hanouneh I; Grove D; Lopez R; Dweik R
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):82-7. PubMed ID: 24284369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.
    Hicks LC; Huang J; Kumar S; Powles ST; Orchard TR; Hanna GB; Williams HR
    J Crohns Colitis; 2015 Sep; 9(9):731-7. PubMed ID: 26071410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A rapid method for breath analysis in cystic fibrosis patients.
    Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Resolution Magic Angle Spinning NMR-Based Metabolomics Revealing Metabolic Changes in Lung of Mice Infected with P. aeruginosa Consistent with the Degree of Disease Severity.
    LeGouëllec A; Moyne O; Meynet E; Toussaint B; Fauvelle F
    J Proteome Res; 2018 Oct; 17(10):3409-3417. PubMed ID: 30129763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
    Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
    J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a least absolute shrinkage and selection operator (LASSO) model to selected ion flow tube mass spectrometry (SIFT-MS) analysis of exhaled breath to predict the efficacy of dialysis: a pilot study.
    Wang MH; Chong KC; Storer M; Pickering JW; Endre ZH; Lau SY; Kwok C; Lai M; Chung HY; Ying Zee BC
    J Breath Res; 2016 Sep; 10(4):046004. PubMed ID: 27677705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometry.
    Purkhart R; Köhler H; Liebler-Tenorio E; Meyer M; Becher G; Kikowatz A; Reinhold P
    J Breath Res; 2011 Jun; 5(2):027103. PubMed ID: 21512209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of acute respiratory distress syndrome (DARTS) by bedside exhaled breath octane measurements in invasively ventilated patients: protocol of a multicentre observational cohort study.
    Hagens LA; Heijnen NFL; Smit MR; Verschueren ARM; Nijsen TME; Geven I; Schultz MJ; Bergmans DCJJ; Schnabel RM; Bos LDJ
    Ann Transl Med; 2021 Aug; 9(15):1262. PubMed ID: 34532399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability in the concentrations of volatile metabolites emitted by genotypically different strains of Pseudomonas aeruginosa.
    Shestivska V; Spaněl P; Dryahina K; Sovová K; Smith D; Musílek M; Nemec A
    J Appl Microbiol; 2012 Sep; 113(3):701-13. PubMed ID: 22726261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns.
    Itoh T; Miwa T; Tsuruta A; Akamatsu T; Izu N; Shin W; Park J; Hida T; Eda T; Setoguchi Y
    Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27834896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis.
    Enderby B; Smith D; Carroll W; Lenney W
    Pediatr Pulmonol; 2009 Feb; 44(2):142-7. PubMed ID: 19148935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct examination and cultures of bronchoalveolar lavage in pneumonia diagnosis: a comparative experimental study.
    Brandão da Silva N; Martins L; Martins F; Anflor J; Tonietto T; Koefender C; Cardoso PG; Moreira J
    Intensive Care Med; 2007 Oct; 33(10):1840-7. PubMed ID: 17673974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of metabolomic profiles obtained using chemical ionization and electron ionization MS in exhaled breath.
    Turner MA; Guallar-Hoyas C; Kent AL; Wilson ID; Thomas CL
    Bioanalysis; 2011 Dec; 3(24):2731-8. PubMed ID: 22185273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breath analysis for noninvasively differentiating Acinetobacter baumannii ventilator-associated pneumonia from its respiratory tract colonization of ventilated patients.
    Gao J; Zou Y; Wang Y; Wang F; Lang L; Wang P; Zhou Y; Ying K
    J Breath Res; 2016 Jun; 10(2):027102. PubMed ID: 27272697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Volatile fingerprinting of Pseudomonas aeruginosa and respiratory syncytial virus infection in an in vitro cystic fibrosis co-infection model.
    Purcaro G; Rees CA; Melvin JA; Bomberger JM; Hill JE
    J Breath Res; 2018 Jul; 12(4):046001. PubMed ID: 29735804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls.
    Robroeks CM; van Berkel JJ; Dallinga JW; Jöbsis Q; Zimmermann LJ; Hendriks HJ; Wouters MF; van der Grinten CP; van de Kant KD; van Schooten FJ; Dompeling E
    Pediatr Res; 2010 Jul; 68(1):75-80. PubMed ID: 20351658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.